Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$620K Buy
11,742
+2,943
+33% +$156K 0.17% 118
2026
Q1
$490K Sell
8,799
-1,907
-18% -$103K 0.17% 102
2025
Q4
$529K Buy
10,706
+582
+6% +$27.1K 0.19% 87
2025
Q3
$441K Buy
10,124
+1,211
+14% +$47.3K 0.17% 94
2025
Q2
$342K Buy
8,913
+48
+0.5% +$1.83K 0.15% 93
2025
Q1
$343K Sell
8,865
-1,659
-16% -$60.7K 0.15% 85
2024
Q4
$356K Buy
10,524
+1,226
+13% +$44.1K 0.15% 92
2024
Q3
$380K Buy
9,298
+30
+0.3% +$1.23K 0.18% 84
2024
Q2
$357K Buy
+9,268
New +$390K 0.19% 83

Other funds holding GSK

New Wave Wealth Advisors's GSK Position: Q2 2026 in Review

New Wave Wealth Advisors increased its GSK (GSK) stake by 33% in Q2 2026, buying an estimated $156K and bringing the position to 11,742 shares worth $620K. The position accounts for 0.17% of the portfolio, ranked #118.

New Wave Wealth Advisors first reported a position in GSK in Q2 2024 and has held it in 9 quarters since. 368 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • New Wave Wealth Advisors held 11,742 shares of GSK worth $620K as of Q2 2026.
  • New Wave Wealth Advisors bought 2,943 GSK shares in Q2 2026, an estimated $156K.
  • GSK made up 0.17% of New Wave Wealth Advisors's portfolio in Q2 2026, its #118 holding.
  • New Wave Wealth Advisors first reported a position in GSK in Q2 2024 and has held it in 9 quarters since.
  • 368 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on New Wave Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.